MedTrace Logo

NIPD of CFTC by WGA Coupled to Mini-exome Sequencing

NCT03743948 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2019-09-27

No results posted yet for this study

Summary

The purprose of this study is to develop a single test based on circulating fetal trophoblastic cells (CFTC) analysis from maternal blood, searching for the familial mutation for a wide range of monogenic diseases.

Conditions

  • Monogenic Diseases

Interventions

GENETIC

Non invasive prenatal diagnosis

15 pregnant women and their spouses Search for the familial mutation on isolated circulating fetal trophoblastic cells from maternal blood

Sponsors & Collaborators

  • ABM Industries

    collaborator OTHER

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Claire Guissart, PhD-PharmD · molecular genetics

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-19
Primary Completion
2019-08-27
Completion
2019-12-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743948 on ClinicalTrials.gov